INTRODUCTION
Ovarian malignancy is one of the gynaecological malignancies with highest case to fatality ratio. The best treatment is staging laparotomy with primary debulking with minimal or no residual disease followed by adjuvant chemotherapy. The appendix is an intraperitoneal organ in 95% of the cases and prone to metastatic involvement by epithelial ovarian cancers. 1 This study was done with the aim to analyze the importance of appendicectomy in patients with epithelial ovarian cancer and to demonstrate the possible relationship with clinico-pathologic variables.
METHODS
This was a retrospective study conducted from Jan 2011 to April 2014. Women who underwent primary as well as interval cytoreductive surgery for ovarian cancer in which appendicectomy was performed were enrolled in this study. Patients who did not have appendicectomy for other reasons (prior appendicectomy, personal preference of the surgeons) and the patients with incomplete clinicopathologic data were all excluded from the study. Those women who had undergone secondary cytoreductive and completion surgery were excluded from our study. All patients were subjected to initial surgical staging procedure according to the recommendations of the International federation of gynecology and obstetrics. Demographic data, age, parity, body surface area, tumor markers: Ca 125, CEA, Ca-19.9 and detailed histopathological findings were recorded and analysed from medical records.
Statistical analysis: All the data were analyzed with Epiinfo and SP SS software. Quantitative variables were summarized by means and SD variables, following non normal distribution. Categorical variables were summarized by frequencies (%) and were compared with Pearson Chi-Sq test or fisher -exact test. The Odd Ratio and their correspondence 95% Confidence interval was calculated using unconditional multiple logistic regression analysis.
RESULTS
Demographic information, potential risk factors and surgical indications were recorded. 
DISCUSSION
Comprehensive surgical staging and the optimal or maximal cytoreduction are the most important objectives of treatment in epithelial ovarian carcinoma. Ovarian cancer has a well-established widespread peritoneal dissemination. [2] [3] [4] Although the surface of the appendix constitutes less than 1% of the peritoneal cavity, it is suggested as a frequent metastatic site. In our study, the overall incidence of metastasis to appendix in ovarian cancer was 50.98%. Maximum number 60.7% (48/79) of appendiceal metastasis was seen in serous adenocarcinoma. This may be due to the high prevalence of serous histology in our study. All appendiceal metastasis in our study were seen in advanced cases (stage III and IV) of ovarian cancer. None of early case of ovarian cancer (stage I and II) shows metastasis to appendix. This was in accordance with the studies conducted by Rose et al, Malfetano and Takac who reported similar high rates in stage III-IV disease (69.7%, 69-75% and 54.2% respectively). 1, 5, 6 Ayhan et al concluded that routine appendectomy is indicated in all cases of epithelial ovarian malignancy as part of the initial surgical staging procedure because of considerable rate of upstaging in early stage disease and optimal cyto reduction in advanced stages. 7 Our study shows significantly higher chance of involvement of appendix in whom omentum, lymphnode were positive for malignancy (O.R: 13.7, P: 0.002; O.R: 6.6, P: 0.002; respectively). Though statistically not significant, women having right or bilateral tumors, CA 125 value >500u/ml and positive peritoneal cytology also had higher chance of appendiceal metastasis. Chae Hyeong et al shows no significant relationship between appendiceal metastases and preoperative CA 125 level. 8 On the contrary Ayhan et al found that pre operative CA 125 >500u/ml was found to be significantly related to appendiceal metastases. 7 In our study, maximum tumor diameter >10cms was not found to be a significant factor determining the appendiceal metastasis. This was because bigger tumor size in our study was mostly seen in borderline tumors and was in early stages. A similar finding was also reported by Chae Hyeong et al. 8 On the contrary, Ayhan et al reported that maximum diameter of tumor >10cm was a significant risk factor. 7 Similar to our study Fontanelli reported a higher prevalence appendiceal involvement in patients with right sided tumor. 9 The reason behind this is due to close proximity of the tumors to the appendix.
The limitation of our study is that it was a retrospective study and segregation of gross and microscopic metastasis to appendix was not done. Also there were only limited cases of early stages of ovarian malignancy where appendectomy was done, thus it was difficult to draw conclusion that routine appedicectomy should be a part of comprehensive surgical staging in early stage. So for this, there is a need of prospective randomized controlled trial.
CONCLUSION
The study showed that appendicectomy should be a part of cytoreductive surgery even in non mucinous ovarian cancer especially when omentum and lymphnodes are involved or in advanced stages as routinely appendicectomy only slightly increases the operating time but at the same time might improve the survival without significantly increasing the morbidity of the patient.
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